U.S. Physical Therapy, Inc.
USPH
Positions held
Your positionsUSPH isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- The healthcare sector is experiencing a strong demand for physical therapy services, positioning U.S. Physical Therapy, Inc. favorably within the industry cycle.
- Revenue increased by 8% compared to the prior quarter, reaching $214 million.
- Gross margin improved to 19.6%, up from 16.5% in the previous quarter.
- The company's trailing P/E ratio is significantly high at 464.61, indicating potential overvaluation.
- Net income for Q1 2026 was negative at -$4.331 million, reflecting ongoing profitability challenges.
- Earnings growth has declined by 56.5%, raising concerns about future performance.
Fundamentals
| Market cap | $1.25B | Enterprise value | $1.92B | Trailing P/E | 464.00 | Forward P/E | 24.93 |
| PEG | 2.72 | Price / book | 2.78 | Beta | 1.11 | Dividend yield | 2.20% |
| Revenue growth | 8.5% | Earnings growth | -56.5% | Gross margin | 21.5% | Operating margin | 11.1% |
| Profit margin | 4.0% | ROE | 6.5% | ROA | 4.1% | Debt / equity | 0.50 |
| Current ratio | 1.27 | Free cash flow | $41.29M | Analyst recommendation | none | Mean target | $97.00 |
| 52w high | $93.50 | 52w low | $58.19 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $214M | $198M | $203M | $197M | $197M |
| Op margin | 10.7% | 7.3% | 10.9% | 9.9% | 12.2% |
| Net income | $1.6M | -$4.3M | -$10.5M | $5.2M | $7.6M |
| Gross margin | 19.6% | 16.5% | 19.8% | 18.7% | 21.1% |
| Gross profit | $41.9M | $32.8M | $40.1M | $36.9M | $41.6M |
| Operating income | $22.9M | $14.5M | $22.0M | $19.5M | $24.1M |
- Revenue +8% vs prior quarter ($214M vs $198M).
- Gross margin 19.6% (was 16.5% prior quarter).
- Operating margin expanded to 10.7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $781M | $671M | $605M | $553M | — |
| Op margin | 10.3% | 9.8% | 11.6% | 11.9% | — |
| Net income | $15.1M | $26.5M | $14.7M | $28.3M | — |
| Gross margin | 19.2% | 18.5% | 20.1% | 20.3% | — |
| Gross profit | $150M | $124M | $122M | $112M | — |
| Operating income | $80.4M | $65.6M | $70.0M | $65.9M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-02 · Why Concentra’s Quiet Healthcare Business Keeps Winning
2026-09-30 · 3 Cash-Producing Stocks with Questionable Fundamentals
2026-09-21 · U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
2026-09-21 · U.S. Physical Therapy (USPH), What Is Drawing Fresh Attention Now?
2026-09-21 · Will a New CFO and Tighter Cash Flow Lens Change U.S. Physical Therapy's (USPH) Narrative
2026-09-20 · U.S. Physical Therapy (USPH) Stock Could Be 44% Undervalued After CFO Appointment
2026-09-14 · US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO
2026-08-27 · U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
2026-08-27 · U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
2026-08-24 · 2 Small-Cap Stocks with Promising Prospects and 1 We Avoid
2026-08-14 · US Physical Therapy Names Nchacha Etta as Chief Financial Officer
2026-08-14 · U.S. Physical Therapy Announces CFO
Price (daily)
Full chart · RSI · MACD · patterns